Consolidated Statements of Cash Flows € in Thousands, $ in Thousands	9 Months Ended
	Apr. 30, 2019 USD ($)	Apr. 30, 2018 USD ($)
Cash flows from operating activities:
Net income	$ 39,974	$ 341,946
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	47,134	28,270
Amortization of intangibles	50,376	41,236
Amortization of debt issuance costs	3,441	1,177
Foreign currency forward contract loss	70,777
Deferred income tax provision	2,218	18,030
(Gain) loss on disposition of property, plant and equipment	127	(1,465)
Stock-based compensation expense	14,118	12,986
Changes in assets and liabilities:
Accounts receivable	17,438	(173,388)
Inventories	145,049	(146,697)
Prepaid income taxes, expenses and other	(9,090)	(14,141)
Accounts payable	(95,849)	29,595
Guarantee liabilities related to former EHG subsidiaries	(105,343)
Accrued liabilities	(5,182)	49,383
Long-term liabilities and other	614	10,253
Net cash provided by operating activities	175,802	197,185
Cash flows from investing activities:
Purchases of property, plant and equipment	(83,749)	(100,021)
Proceeds from dispositions of property, plant and equipment	1,281	3,656
Business acquisitions, net of cash acquired	(1,658,577)
Foreign currency forward contract payment related to business acquisition	(70,777)
Equity investment in joint venture	(5,250)	(46,902)
Other	0	1,271
Net cash used in investing activities	(1,817,072)	(141,996)
Cash flows from financing activities:
Borrowings on term-loan credit facilities	2,095,018
Borrowings on revolving credit facilities	100,000
Principal payments on term-loan credit facilities	(1,732)
Principal payments on revolving credit facilities	(40,000)	(65,000)
Principal payments on unsecured notes	(84,728)
Principal payments on other debt	(70,319)
Payments of debt issuance costs	(69,220)
Regular cash dividends paid	(62,664)	(58,492)
Principal payments on capital lease obligations	(301)	(279)
Payments related to vesting of stock-based awards	(4,418)	(7,657)
Other	(6,092)
Net cash provided by (used in) financing activities	1,855,544	(131,428)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(2,610)
Net increase (decrease) in cash and cash equivalents and restricted cash	211,664	(76,239)
Cash and cash equivalents and restricted cash, beginning of period	275,249	223,258
Cash and cash equivalents and restricted cash, end of period	486,913	147,019
Less: restricted cash	25,801
Cash and cash equivalents, end of period	461,112	147,019
Supplemental cash flow information:
Income taxes paid	69,872	186,166
Interest paid	24,714	3,087
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	6,125	$ 2,082
Common stock issued for business acquisition	$ 144,168